详情页 - 河北医科大学第四医院机构库

当前位置：首页 > 详情页

Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)-China Extension

8| 链接全文 |

文献详情

编号/登记号：

注册时间：

研究开始时间：

研究结束时间：

项目类型：

本院角色：

多中心研究：

招募状态：

试验分期：

研究疾病/适应症：

研究类型：

研究参与人：

研究单位： [1]Merck Sharp & Dohme LLC [2]Beijing Friendship Hospital ( Site 0637) Beijing, Beijing, China, 100050 [3]Beijing Cancer Hospital ( Site 0221) Beijing, Beijing, China, 100142 [4]Fujian Medical University Union Hospital-1 Bingfanglou-Gastric Surgery Department (Site 0632) Fuzhou Fujian, Fujian, China, 350001 [5]Fujian Provincial Cancer Hospital ( Site 0230) Fuzhou, Fujian, China, 350014 [6]The First Affiliated Hospital, Sun Yat-sen University (Site 0635) Guangzhou, Guangdong, China, 510080 [7]The First Affiliated Hospital of Guangzhou Medical University ( Site 0224) Guangzhou, Guangdong, China, 510120 [8]Fourth Hospital of Hebei Medical University ( Site 0633) Shijiazhuang, Hebei, China, 050035 [9]Henan Cancer Hospital (Site 0227) Zhengzhou, Henan, China, 450008 [10]The Affiliated Hospital of Xuzhou Medical College-Oncology ( Site 0645) Xuzhou, Jiangsu, China, 221006 [11]The First Hospital of Jilin University-Gastrointestinal Surgery ( Site 0234) Changchun, Jilin, China, 130021 [12]Tangdu Hospital of Fourth Military Medical University of Chinese People's Liberation Army ( Site 0647) Xi'an, Shaanxi, China, 710038 [13]Shandong Provincial Hospital-Gastrointestinal Surgery ( Site 0640) Jinan, Shandong, China, 250001 [14]The Affiliated Hospital of Qingdao University ( Site 0636) Qingdao, Shandong, China, 266003 [15]Renji Hospital Shanghai Jiao Tong University School of Medicine ( Site 0642) Shanghai, Shanghai, China, 200127 [16]Sichuan Cancer hospital Chengdu, Sichuan, China, 610041 [17]Zhejiang Provincial People's Hospital-Oncology (Site 0656) Hangzhou, Zhejiang, China, 310014 [18]Zhejiang Cancer Hospital ( Site 0231) Hangzhou, Zhejiang, China, 310022 [19]Sir Run Run Shaw Hospital ( Site 0233) Hangzhou, Zhejiang, China, 430030 [20]Afflilated Hospital of Bengbu Medical College-Surgical Oncology (Site 0638) Bengbu, Anhui, China, 233004

关键词： Programmed Cell Death-1 (PD1 PD-1) Programmed Death-Ligand 1 (PDL1 PD-L1)

研究目的：

The purpose of this study is to evaluate the efficacy of pembrolizumab (MK-3745) in the neoadjuvant (prior to surgery) or adjuvant (after surgery) treatment of previously untreated Chinese adults with gastric and gastroesophageal junction (GEJ) adenocarcinoma. No formal hypothesis testing will be done